CoChat

Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation

Rimmelé, Pauline, Kosmider, Olivier, Mayeux, Patrick, Moreau-Gachelin, Françoise, Guillouf, Christel · 2007 · Blood

The DOI matches its Crossref record; 56 of the 56 references it cites were found in a registry or an index.

Abstract

Overexpression of the transcription factor Spi-1/PU.1 in mice leads to acute erythroleukemia characterized by a differentiation block at the proerythroblastic stage. In this study, we made use of a new cellular system allowing us to reach graded expression of Spi-1 in preleukemic cells to dissect mechanisms of Spi-1/ PU-1 in erythroleukemogenesis. This system is based on conditional production of 1 or 2 spi-1-interfering RNAs stably inserted into spi-1 transgenic proerythroblasts. We show that Spi-1 knock-down was sufficient to reinstate the erythroid differentiation program. This differentiation process was associated with an exit from the cell cycle. Evidence is provided that in the presence of erythropoietin (Epo), Spi-1 displays an antiapoptotic role that is independent of its function in blocking erythroid differentiation. Apoptosis inhibited by Spi-1 did not involve activation of the Fas/FasL signaling pathway nor a failure to activate Epo receptor (EpoR). Furthermore, we found that reducing the Spi-1 level yields to ERK dephosphorylation and increased phosphorylation of AKT and STAT5, suggesting that Spi-1 may affect major signaling pathways downstream of the EpoR in erythroid cells. These findings reveal 2 distinct roles for Spi-1 during erythroleukemogenesis: Spi-1 blocks the erythroid differentiation program and acts to impair apoptotic death in cooperation with an Epo signaling.

Overview

Integrity signals

Registry

Crossref · 10.1182/blood-2006-03-006718

Cites

56 of 56 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 56 references

Cited by

See all 35

Metadata

Authors
Rimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C.
Affiliations
  • Institut Curie, Institut National de la Santé et de la Recherche Médicale (INSERM) Unité 528, Paris, France;
  • Inserm (FR)
  • Institut Cochin (FR)
Venue
Blood
Published
2006-11-28
Volume
109
Issue
7
Pages
3007-3014
ISSN
  • 0006-4971 (ISSN-L)
  • 1528-0020
OpenAlex
W1982658542
Cited by
35
References
53
Citations by year
2026: 1 · 2025: 1 · 2024: 2 · 2023: 1 · 2022: 1 · 2021: 6 · 2020: 2 · 2017: 2 · 2016: 1 · 2014: 1 · 2013: 1 · 2012: 4
FWCI
1.42
Type
journal article
Language
en
Open access
closed
Locations
  • Blood (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
  • Health Sciences › Medicine › Hematology › Erythropoietin and Anemia Treatment
  • Health Sciences › Medicine › Hematology › Hematopoietic Stem Cell Transplantation
Keywords
erythroleukemia, apoptosis inhibition, erythropoietin signaling, erythropoietin receptor, proerythroblasts, RNA knockdown, ERK dephosphorylation, Akt phosphorylation, STAT5, Fas/FasL signaling, cell cycle exit, transcription factor overexpression
MeSH terms
Proto-Oncogene Protein Spi-1, Animals, Base Sequence, Cell Cycle, Cell Differentiation, Erythroblasts, Leukemia, Erythroblastic, Acute, Erythropoiesis, Erythropoietin, Humans, Mice, Transgenic, Proto-Oncogene Proteins, Signal Transduction, Trans-Activators, Apoptosis, Receptors, Erythropoietin, RNA, Small Interfering, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. https://app.cochat.ai/papers/10.1182/blood-2006-03-006718
The paper
Rimmelé, P., Kosmider, O., Mayeux, P., Moreau-Gachelin, F., & Guillouf, C. (2007). Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation. Blood. https://doi.org/10.1182/blood-2006-03-006718

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.